Zions Bancorporation N.A. Makes New Investment in Stevanato Group S.p.A. (NYSE:STVN)

Zions Bancorporation N.A. acquired a new stake in shares of Stevanato Group S.p.A. (NYSE:STVN) during the third quarter, Holdings Channel reports. The fund acquired 52,462 shares of the company’s stock, valued at approximately $1,049,000.

Several other large investors have also recently modified their holdings of STVN. Conestoga Capital Advisors LLC increased its stake in Stevanato Group by 5.5% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock worth $153,518,000 after purchasing an additional 400,087 shares during the period. Clearbridge Investments LLC increased its stake in shares of Stevanato Group by 13.1% in the first quarter. Clearbridge Investments LLC now owns 1,729,397 shares of the company’s stock worth $55,514,000 after buying an additional 200,753 shares during the period. Thrivent Financial for Lutherans bought a new stake in Stevanato Group during the 2nd quarter valued at $30,477,000. Bamco Inc. NY boosted its position in Stevanato Group by 37.1% during the 1st quarter. Bamco Inc. NY now owns 1,288,814 shares of the company’s stock valued at $41,371,000 after buying an additional 348,728 shares during the period. Finally, Pembroke Management LTD grew its holdings in Stevanato Group by 143.7% in the 3rd quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock worth $21,023,000 after acquiring an additional 619,747 shares during the last quarter.

Stevanato Group Price Performance

Stevanato Group stock opened at €20.50 ($21.81) on Friday. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($17.62) and a fifty-two week high of €34.73 ($36.95). The stock’s 50 day simple moving average is €19.60 and its two-hundred day simple moving average is €20.11. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. During the same period in the prior year, the business posted $0.16 EPS. The business’s quarterly revenue was up 2.4% compared to the same quarter last year. As a group, equities analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Citigroup dropped their target price on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a report on Wednesday, August 7th.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.